Lobbying

Geneinfosec's latest lobbying report covers Q3 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Defense.

Geneinfosec

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Geneinfosec lobbying by quarter
Geneinfosec lobbying by quarter
QuarterAmountReports
Q4 2022$18K1
Q1 2023$18K1
Q2 2023$12K1
Q3 2023$01
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Defense$48K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES4 reports
  • SENATE4 reports

Firms it paid

Firm
Revere Federal Strategies$48K4 quarters

Former officials lobbying for it

Former position
ERIC SNELGROVEFormer professional staff member with House Armed Services CommitteeQ3 2023

Lobbying reports

Filed by
23/11/14for Q3 2023Revere Federal StrategiesUnder $5,000
23/07/10for Q2 2023Revere Federal Strategies$12K
23/04/19for Q1 2023Revere Federal Strategies$18K
23/01/18for Q4 2022Revere Federal Strategies$18K